The human solute carrier 26 (SLC26) family of anion transporters consists of ten members that are found in various organs in the body including the stomach, intestine, kidney, thyroid and ear where they transport anions including bicarbonate, chloride and sulfate, typically in an exchange mode. Mutations in these genes cause a plethora of diseases such as diastrophic dysplasia affecting sulfate uptake into chondrocytes (SLC26A2), congenital chloride-losing diarrhoea (SLC26A3) affecting chloride secretion in the intestine and Pendred's syndrome (SLC26A4) resulting in hearing loss. To understand how these mutations affect the structures of the SLC26 membrane proteins and their ability to function properly, 12 human disease-causing mutants from SLC26A2, SLC26A3 and SLC26A4 were introduced into the equivalent sites of the sulfate transporter anti-sigma factor antagonist (STAS) domain of a bacterial homologue SLC26 protein DauA (YchM). Biophysical analyses including sizeexclusion chromatography, circular dichroism (CD), differential scanning fluorimetry (DSF) and tryptophan fluorescence revealed that most mutations caused protein instability and aggregation. The mutation A463K, equivalent to N558K in human SLC26A4, which is located within α-helix 1 of the DauA STAS domain, stabilized the protein. CD measurements showed that most disease-related mutants had a mildly reduced helix content, but were more sensitive to thermal denaturation. Fluorescence spectroscopy showed that the mutants had more open structures and were more readily denatured by urea, whereas DSF indicated more labile folds. Overall, we conclude that the disease-associated mutations destabilized the STAS domain resulting in an increased propensity to misfold and aggregate.
INTRODUCTION
The solute carrier 26 (SLC26) proteins are a super-family of anion transporters that is conserved throughout phylogeny in different organisms [1] [2] [3] . The SLC26 membrane proteins transport SO 4 2− in yeast and plants [4] [5] [6] , whereas in mammals a wide range of anions are transported including SO 4 2− , HCO 3 − , Cl − , I − , NO 3− and oxalate [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Most SLC26 proteins contain an N-terminal membrane domain consist of 14 transmembrane (TM) helices followed by a C-terminal cytosolic STAS (sulfate transporter anti-sigma factor antagonist) domain [17] [18] [19] . The membrane domain is predicted to have a similar 14 TM fold to that of UraA, a bacterial proton-uracil symporter with a 7 + 7 TM inverted topology that contains a central substrate-binding site [20] . The crystal structure of a prokaryotic member of the SLC26 family (SLC26Dg) that transports fumarate has confirmed this topology [21] . The STAS domain has been reported to have various functions but is named based on its structural similarity to Bacillus subtilis SpoIIAA, which regulates bacterial sporulation through binding with sigma factor upon phosphorylation. σ F is a factor that binds to RNA polymerase to confer forespore-specific gene expression, whereas the anti-sigma factor SpoIIAB is a serine/threonine kinase and an antagonist of SpoIIAA [22] [23] [24] . Some STAS domains are nucleotide-binding phosphoproteins or nucleotidases, whereas others are the interaction or transduction modules [3, 24, 25] . STAS domains in human SLC26 proteins are important in protein-protein interactions such as interacting with CFTR (cystic fibrosis transmembrane conductance regulator) [26] [27] [28] [29] . The sole member of the SLC26 (SulP) family found in Escherichia coli is DauA (YchM), annotated in EcoCyc (http://www.ecocyc.org) to be involved in succinate, fumarate and L-aspartate transport.
DauA plays a role in the regulation of C 4 -dicarboxylic acid metabolism at pH 7, via regulation of expression and/or activity of DctA, and it may act as a co-sensor with DcuS [25, 30] . The structure of E. coli DauA STAS domain (PDB code 3NY7) adopts a β1-β2-α1-β3-α2-β4-α3-β5-α4 secondary structure that is common to other STAS domains, although the SLC26Dg fumarate transporter is shorter than DauA and lacks the final α4-helix. This core STAS domain of DauA overlays with the rat SLC26A5 (prestin) structure (PDB code 3LLO) in which an intervening loop between α1 and β3 was deleted for structure determination. In addition, the prestin STAS domain contains an extra β-strand (β0) in its N-terminal region [25, 31, 32] . A structure of a human SLC26 STAS domain is still not available. In humans, the SLC26 family consists of ten different membrane proteins that are found in various tissues in the body including the stomach, intestine, kidney, thyroid and ear where they typically transport ions including bicarbonate, chloride and sulfate in an exchange mode [3, [33] [34] [35] . Mutations within these genes cause a range of diseases including diastrophic dysplasia in the case of SLC26A2 [36] [37] [38] [39] [40] [41] [42] [43] [44] , intestinal congenital chloride-losing diarrhoea (CCD) in SLC26A3 [8, 18, 45] and Pendred's syndrome (deafness) in case of SLC26A4 [46] [47] [48] [49] . Studies of mouse models also generated similar phenotypes of diseases such as distal renal tubular acidosis [50] , gastric achlorhydria [50, 51] , nephrolithiasis [52, 53] , pancreatic duct defects [54, 55] and altered regulation of bicarbonate secretion [56] . Despite their importance in human physiology and disease, solute transporters, including the SLC26 family, remain one of the most poorly studied of all human gene families [57] . Many of these disease-causing mutations are located within the STAS domain. To understand the molecular basis of these diseases, previous studies examined a limited number of mutations within the STAS domain that cause misfolding of SLC26 or trafficking defects in cells [31, 58] . A comprehensive study of the effects of the mutations on the behaviour of SLC26 proteins itself is still not available. Therefore an in vitro study of the folding and stability of these mutants is needed in order to give a systematic overview on how mutations give rise to disease at the structural level. Previously we have solved the structure of the E. coli DauA STAS domain, which is readily expressed in bacterial cells with good behaviour in solution [25] . This structure carries a similar fold to other STAS structures. There is only one reported STAS structure from mammals (Rattus norvegicus); however, it was determined by deleting a significant ([505-553]GS[637-718]) [31] intervening loop portion of the protein revealing the core STAS domain. In addition, no tryptophan residues are found in this rat prestin sequence, limiting spectroscopic studies using this natural fluorescent reporter. Based on this, we performed various biophysical analyses on the effect of human SLC26A3, SLC26A4 and SLC26A5 mutations introduced into homologous positions in the E. coli DauA STAS domain as a template to determine the effect of these disease-causing mutations on protein stability and folding.
EXPERIMENTAL

Materials
The pET28b expression vector was supplied by Invitrogen. The Q5 ® Site-Directed Mutagenesis Kit was from New England BioLabs. Chemicals for bacteria-culturing media and IPTG were from BioShop. Trypsin was obtained from Hampton Research. Urea was from Thermo Scientific. Other chemicals were purchased from Sigma-Aldrich. Mouse anti-His antibody was purchased from Thermo Scientific and the secondary antibody horseradish peroxidase (HRP)-linked anti-mouse (or anti-rabbit) IgG was from Cell Signaling Technology.
Gene cloning and plasmid constructs
The DauA STAS domain (residues Met 436 -Leu 550 ) construct was amplified by polymerase chain reaction (PCR) from the fulllength DauA cDNA and then inserted into a pET28b expression vector fused with an N-terminal His 6 tag. Disease-related mutants were created from the wild-type STAS constructs and also cloned into the pET28b expression vector using the Q5 ® Site-Directed Mutagenesis Kit and the complementary mutagenic primers. All DNA sequences were confirmed by DNA sequencing using GeneSifter at the TCAG sequencing facility at the Hospital for Sick Children, Toronto, Ontario, Canada.
Protein expression assessment
Proteins (wild-type and STAS mutants) were expressed in parallel in 4 ml of BL21(DE3)plysS and cells were grown until the D 600 reached 1.0. Induction was performed with the final concentration of 1 mM ITPG at 20
• C for 18 h. Cells were centrifuged for 1 min at 15 700 g (Eppendorf Centrifuge 5415R, rotor F45-24-11). The pellets were resuspended with 60 μl of 200 mM sodium chloride and 20 mM Tris/HCl, pH 8.0, and then the same volume of SDS sample buffer was added. Protein expression was detected by immunoblotting using a mouse anti-His (and then rabbit anti-LepB for protein loading) antibody followed by HRP-linked mouse (or rabbit) anti-IgG secondary antibody. LepB (Signal peptidase I) is an endogenous protein expressed in bacteria which functions in the cleavage of hydrophobic, Nterminal signal or leader sequences from secreted and periplasmic proteins (http://www.uniprot.org/uniprot/P00803). Here we used rabbit anti-LepB antibody [59] .
Protein purification
His-tagged proteins were expressed in E. coli BL21(DE3)plysS cells (Novagen) and cells were cultured in 20 ml of LB medium (20 g/l tryptone, 10 g/l yeast extract and 10 g/l NaCl) with 50 mg/l kanamycin in 125 ml flasks. Large-scale cultivation was performed in 5 litre baffled flasks containing 2 litres of medium. Cells were grown at 37
• C at 210 rev./min until reaching a D 600 of ∼1.0. Protein expression was induced by adding a 1 mM final concentration of IPTG and cultivation was continued at 18
• C at 210 rev./min for 20 h. Cell pellets were harvested by centrifugation at 4000 g for 20 min at 4
• C, and resuspended in buffer containing 20 mM Tris/HCl, pH 8.0, 300 mM NaCl and 1 % glycerol. After disruption in a French Press (Thermo Spectronic) at 100 MPa, the crude cell extract was separated from cell debris by centrifugation (40 000 g, 4
• C, 30 min). The protein in the supernatant was purified by nickel-affinity and gel-filtration chromatography as described previously [60] . The purity of the resulting proteins was ascertained by SDS/PAGE to be more than 90 % pure. Purified proteins were concentrated by centrifugal ultrafiltration and the protein concentration was determined by absorbance measurements at 280 nm using calculated absorption coefficients. The final protein yield of wild-type STAS domain from 1 litre of cell culture was ∼2 mg.
Mass spectrometry
Samples were analysed on a linear ion trap-Orbitrap hybrid analyser (LTQ-Orbitrap, ThermoFisher) outfitted with a nanospray source and EASY-nLC split-free nano-LC system (ThermoFisher). Freeze-dried peptide mixtures were dissolved in 0.1 % formic acid and loaded on to a 75 μm × 15 cm PepMax RSLC EASY-Spray column filled with 2 μM C 18 beads (ThermoFisher) at a pressure of 80 000 kPa. Peptides were eluted over 60 min at a rate of 250 nl/min using a 0-35 % acetonitrile gradient in 0.1 % formic acid. Peptides were introduced by nano electrospray into an LTQ-Orbitrap hybrid mass spectrometer (ThermoFisher). The instrument method consisted of one MS full scan (400-1500 m/z) in the Orbitrap mass analyser, an automatic gain control target of 500 000 with a maximum ion injection of 200 ms, one microscan and a resolution of 120 000. Ten datadependent MS/MS scans were performed in the linear ion trap using the ten most intense ions at 35 % normalized collision energy. The MS and MS/MS scans were obtained in parallel fashion. In MS/MS mode, automatic gain control targets were 10 000 with a maximum ion injection time of 100 ms. A minimum ion intensity of 1000 was required to trigger an MS/MS spectrum. The dynamic exclusion was applied using a maximum exclusion list of 500 with one repeat count with a repeat duration of 15 s and exclusion duration of 45 s.
Circular dichroism (CD)
Far-UV CD spectra were collected in a 1-mm-pathlength quartz cell in a Jasco J-810 CD spectropolarimeter. Experiments were performed at room temperature using 0.35 mg/ml protein in 150 mM NaCl and 25 mM sodium phosphate buffer (pH 8.0). Data were recorded from 260 to 185 nm at 1 nm intervals. Data recorded in the 190-240 nm range were analysed using DichroWeb [61, 62] . The mean residue ellipticity was measured as a function of wavelength. Thermal stability melting curves were determined by CD with the temperature increasing from 20
• C to 80
• C with the wavelength set at 222 nm to monitor helical content.
Intrinsic fluorescence emission and urea denaturation assay
Purified protein samples were centrifuged at 15 700 g (Eppendorf Centrifuge 5415R, rotor F45-24-11) to remove insoluble material and then mixed with various amounts of a 10 M urea stock solution. The final concentration of the protein was 0.075 mg/ml and the final concentration of urea ranged from 0 to 8 M. Protein samples were equilibrated at room temperature for 20 min prior to fluorescence measurements. Tryptophan fluorescence emission was measured at each urea concentration from 300 to 420 nm upon excitation at 295 nm.
Differential scanning fluorimetry (DSF)
DSF was performed on a CFX96 instrument (Bio-Rad Laboratories). Purified STAS domain or mutant proteins were diluted to a final concentration of 1 mg/ml by mixing with 5× SYPRO Orange (Life Technologies) in 40 μl of solution. To generate the DSF melting curve, fluorescence was measured using the FRET channel of the CFX96 instrument between 20
• C and 90
• C. The melting temperature was determined from the peak(s) of the first derivatives of the melting curve and calculations were made using the Bio-Rad Laboratories CFX Manager software.
Trypsin digestion assay
For trypsin digestion, the target protein at 1 mg/ml was incubated with various concentrations of trypsin and set for different incubation times at room temperature as indicated in the figures. The reaction was stopped by addition of SDS/PAGE sample buffer.
Immunoblotting
Proteins were resolved by SDS/PAGE using 18 % polyacrylamide and transferred on to nitrocellulose for immunoblot analysis. All blots were probed using the mouse monoclonal anti-His antibody (Thermo Scientific) and HRP-linked anti-mouse IgG (Cell Signaling Technology). Expression levels of wild-type STAS domain and mutants were normalized for protein loading by the band intensity of endogenous LepB using a rabbit monoclonal anti-LepB antibody and HRP-linked anti-rabbit IgG (Thermo Scientific). Bands were quantified using NIH ImageJ.
RESULTS
Similarities between E. coli and mammalian SLC26 STAS domain
To study the folding effects of different mutations upon the wildtype STAS domain, we mapped 12 disease-causing mutations in human SLC26 STAS proteins on to equivalent position in the E. coli DauA STAS domain ( Figure 1 ). Figure S1A) in containing five or six β-sheets and four α-helix regions (RMSD 2.9). Except for α-helix 1, most of the residues superimpose very well on the structure between E. coli DauA and rat prestin (Supplementary Figure S1B) . As opposed to the human proteins, the E. coli STAS domain can be readily expressed in bacteria and purified to homogeneity. In addition, the E. coli STAS domain contains a single tryptophan residue (Trp 485 in β3; Figure 1 ), a useful intrinsic fluorescence probe.
Protein yield comparison between wild-type and mutant STAS domains
Misfolded proteins are often subjected to degradation or aggregate to form inclusion bodies when overexpressed in E. coli. Most STAS domain mutants expressed as well or better than the wildtype STAS domain in total cell extracts ( Figure 2 ). However, the F499Q mutation that introduces a polar residue within the core of the STAS domain resulted in almost complete loss of expression relative to the wild-type STAS domain. Mutants G457I, K484N, L506S, N542M, A545N and A546V had total expression levels similar to the wild-type STAS domain. Interestingly, some mutants (L459N/A, A463K, T469Q and D470Y) were expressed at higher levels than the wild-type protein. However, mutants G457I, T469Q, D470Y, K484N, L506S, N542M, A545N and A546V had low solubility with most of protein in the insoluble pellet (inclusion bodies) upon cell lysis (results not shown). Specifically, the solubility of G457I was extremely low. Most of these mutations changed the polarity of the side chain, with five of them making the mutant protein more hydrophobic. We concluded that, among all of the mutations, only L459N, L459A and A463K showed significantly higher yields of soluble protein than wild-type STAS domain. Interestingly, these mutations generally introduced more polar residues at these positions.
Characterization of wild-type and mutant STAS domains by size-exclusion chromatography
We performed size-exclusion chromatography to determine the effect of mutations on the mono-dispersity of the STAS domain protein. The DauA STAS domain migrates at the molecular mass of a monomer (13.8 kDa) by size-exclusion chromatography ( Figure 3 ). Most mutants eluted at a much lower volume suggesting that either they have higher oligomeric states or have begun to unfold and become more asymmetric. According to the migration pattern, the mutants could be classified into three groups (Supplementary Table S1 ). Group 1, including wild-type STAS and A463K eluted at the predicted molecular weight indicating no or weak oligomerization. In group 2, three mutations have strong effects on the protein's elution pattern where oligomeric peaks could be observed, whereas group 3, containing seven mutants, caused the proteins to elute near the void volume suggesting a higher propensity to self-associate and aggregate compared with the other two groups.
Effect of mutations on the secondary structure of STAS domain
CD was performed to compare the secondary structures and stability of wild-type STAS domain and the mutants (Figure 4 , Supplementary Figure S2 ). Although minor individual negative ellipticities at 208 nm were observed with mutants, L506S, N542M, A545N and A546V, the CD spectra indicated that mutations had a modest effect on helical content, and that the secondary structural elements were maintained. A difference, however, was noticed in the behaviour of the mutants to thermal denaturation based on loss of helicity measured at 222 nm. Wildtype STAS has a melting temperature of 61
• C with a high level of co-operativity. Thermal denaturation assays showed that the mutants L459A, A463K, T469Q, D470Y, K484N, R544A and A546V had a slightly reduced melting temperature, whereas the L459N, L506S, N542M and A545N mutants showed a significant decrease in melting temperature ( Figure 4B , Supplementary Table  S1 ). The slopes of the melting curves of the mutants were not as steep as the wild-type protein indicating a loss of co-operative unfolding. Some mutants (e.g. N542M) exhibited a biphasic melting curve, indicating a localized effect of the mutation. Most of the mutations affected the thermal stability of helical elements within the STAS domain.
STAS stability measured by tryptophan fluorescence emission
To further investigate whether disease-causing mutations changed the local folding environment of the STAS domain, we examined the fluorescence properties of the only tryptophan (Trp 485 ) residue of the E. coli STAS domain located at the beginning of β3 (Figure 1 ). Compared with wild-type STAS, most mutants showed a dramatic decrease in emission intensity, combined with a red shift of the emission wavelength ( Figure 5A ). This indicates exposure of the tryptophan to a more polar environment, consistent with an unfolded protein. Only A463K exhibited the same emission profile as wild-type, whereas L459N and T469Q showed a minor change in wavelength and fluorescence intensity, respectively ( Figures 5A and 5B) .
To further understand the consequence of mutations on the stability of the STAS domain, a urea denaturation assay was performed and tryptophan fluorescence emission was also measured from 300 to 420 nm following excitation at 295 nm. In All proteins were purified using a nickel-affinity column followed by separation on a Superdex TM 75 10/300 GL (24 ml, GE Healthcare) column in 20 mM Tris/HCl, pH 8.0, and 300 mM NaCl, with 1 % glycerol and monitored by absorbance at 280 nm. The void volume of the column was at 8 ml and the STAS monomer eluted at 14 ml.
the absence of urea, the mutants displayed a range of red-shifts indicating exposure of the tryptophan to solvent ( Figure 5C ); thus the mutants with the greatest red-shift represent more open structures. Only T469Q and R544A showed a slightly lower wavelength at the beginning compared with wild-type STAS ( Figure 5C ). However, the stabilities of T469Q and R544A fell dramatically when urea was increased to 4 and 2 M, respectively, when compared with wild-type STAS ( Figure 5C ). In addition, the initial intensity of R544A was very low ( Figure 5A ). In summary, except for A463K, most mutants were unfolded and had decreased stabilities to urea denaturation compared with wild-type STAS.
STAS stability measured by differential scanning fluorimetry assay
DSF was performed to further measure the thermal stability of the STAS domain and the mutants. DSF, also called thermal shift assay, is a simple and quick method for probing the folding of a protein as it experiences progressive denaturation while the temperature is increased. Fundamentally, the temperature at which the protein unfolds is measured by an increase in the fluorescence of the dye SYPRO Orange that has affinity for hydrophobic parts of the protein [63] , which are exposed while the protein unfolds. In this experiment, the melting curves show shifts in temperature, suggestive of significantly decreased stability for the mutants L459N, L459A, L506S, N542M and A546V (Table 1 , Supplementary Figure S3 and Supplementary Table S1 ). These data showed similar results to the CD melting assays. Although no increased stability was observed in any mutants, the stability of the A463K mutant did not change compared with wild-type STAS domain, further indicating that A463K does not affect the stability of the STAS domain.
Effect of A463K on sensitivity of the STAS domain to trypsin digestion
A463K seems to be the only mutant to behave similarly to wild-type STAS, based on the above assays. To further confirm whether it is a stabilizing mutant or not, we compared the sensitivity to trypsin digestion of STAS and A463K. Tryptic digestions resulted in similar fragmentations of both proteins into one distinct band just below the intact protein on SDS/PAGE (Supplementary Figure S4) . Samples of trypsin-treated wildtype STAS were subjected to mass spectrometric analysis. The LC-MS/MS analysis identified peptides in the lower band corresponding to STAS domain lacking the C-terminal AAMADL sequence with trypsin cutting at Arg 544 (Supplementary Figure  S5) . There was also a loss of the N-terminal His 6 tag, confirmed by immunoblotting, indicating trypsin cleavage in this region leaving a stable core structure. Compared with wild-type STAS, A463K seems less sensitive to trypsin digestion, and the degrading band can be detected by anti-His immunoblotting, indicating a possible stabilizing effect of A463K on the N-terminal His 6 region.
DISCUSSION
This present study used 12 human SLC26 family disease-related mutations (Table 2) mapped into E. coli DauA STAS domain to systematically determine the effects of these mutations on the folding and stability of the protein. DauA STAS has been shown to be a monomer, which is consistent with most STAS domains in previous studies, except for the STAS dimer observed in YtvA and Sultr1;2 in plants [32, 64] . Based on size-exclusion chromatography, most of the disease-related mutations caused the protein to unfold and self-associate into higher oligomers and aggregate, indicating destabilizing effects of these mutations. Expression and purification assays indicated decreased expression and solubility in all mutants except for L459N, L459A and A463K. Tryptophan fluorescence emission, CD and DSF assays showed that most mutants have less compact structure and decreased thermal stability compared with wild-type STAS. The mutations, however, had various effects on protein expression, solubility and stability and could be placed into three different groups.
Mutations causing no expression or extremely low solubility
Gly 457 (equivalent residues are Ala 542 in rat prestin and Ser 552 in human SLC26A4; Figure 1 and Supplementary Figure S1B) is located on the loop between β2 and α1 of the STAS domain. Glycine is highly important for the flexibility of polypeptides and is commonly found in turns and loops connecting secondary structural elements. We speculate that mutant G457I may decrease the flexibility of the loop and the side-chain orientations inside the STAS domain, leading to the forming of severely misfolded protein. Structure alignment shows that the corresponding residue in rat prestin is Ala 542 (Supplementary Figure S1B) , a similar small residue sitting in the loop between α1 and β2 (β2 is the third β-strand, since the first β-strand is named β0). However, the corresponding residue in human SLC26A4 is serine ( Figure 1A) . Serine is also a common residue in loops [65] . Based on the structural similarity between rat prestin and DauA STAS, we speculate that Ser 552 in human SLC26A4 may also reside on the loop region. Therefore the disease-causing mutant S552I may affect the flexibility and solubility of the protein since isoleucine is a hydrophobic residue that prefers to be buried within the hydrophobic core of a protein rather than a loop region that generally comprises polar residues.
Similarly to Gly 457 , mutation of Phe 499 (Leu 660 in rat prestin and Leu 676 in human SLC26A4; Figure 1 and Supplementary Figure S1B ) located in α2 shows no or extremely low expression (Figures 1 and 2 Figure S7A) . The corresponding residue in rat prestin Leu 660 (α2, Supplementary Figure S1B ) is also located in the hydrophobic core region. Therefore we speculate that the disease-causing mutant L676Q in human SLC26A4 may have a similar effect by interfering the hydrophobic core region of the STAS domain by introduction of a polar residue causing the domain to misfold severely.
Mutations on α1 and the loop connecting α1 and β2
The conserved residue Leu 459 (Ile 544 in rat prestin and Ile 544 in human SLC26A3; Figure 1 and Supplementary Figure S1B) Figure  S6) , implying possible hydrophobic interactions among these residues. A strong trafficking defect of transporter SLC26A3 I544N was observed previously [58] . Therefore, to identify the role of leucine in this region, we mutated the leucine into asparagine and alanine, respectively. The replacement of Leu 459 with alanine has a milder effect than mutation into the more polar asparagine. The CD spectrum from L459N showed a larger decrease in helical content compared with L459A. Data from the melting temperature curve also indicates that L459A is more stable than L459N. Unexpectedly, the fluorescence emission assay showed that L459N has a lower intrinsic wavelength, implying a relatively more compact structure than L459A. However, although differences exist between L459N and L459A, these two mutations both changed the natural folding of the STAS domain from different aspects, implying that there is a specific role for leucine (isoleucine) in this loop that contributes to proper folding.
Most residues on α1 of DauA and human STAS domain are poorly conserved ( Figure 1A) . We speculate that these residues are correlated with the specific IVSs (intervening sequences) that exists in mammalian and plant homologues. Mammalian and plant genes generally encode longer STAS domains compared with bacterial genes [32] . The residues on α1 probably interact with this IVS (∼80 amino acids). Even within mammalian SLC26 family members, some residues are not conserved within all forms ( Figure 1A , Mut4 and Mut5), implying specific folding of α1 in different human SLC26 proteins. This IVS is located at the end of α1 in the rat prestin structure but was deleted due to its interference with crystallization of the domain. Deletion of this IVS region in prestin structure makes the analysis of the structure alignment difficult at the region of α1, since we are not sure the tilting away of prestin α1 from DauA α1 (θ 1 and θ 2 in Supplementary Figure S1A ) is due to the deletion of the IVS or to the endogenous structural difference between DauA and prestin. Therefore, the homologous residues on α1 (Ala 463 , Thr 469 , Asp 470 ) can only be predicted from a primary sequence alignment at the time.
The A463K mutant in α1 (Asn 548 in rat prestin and Asn 558 in human SLC26A4; Figure 1 ) appears to be a stabilizing mutant. The mutation would increase the overall polarity of the domain. In the DauA STAS domain structure, Thr 437 and the positively charged His 435 and Arg 438 are closer to Ala 463 than the other residues (Supplementary Figure S7) . We speculate that an Ala 463 mutation to lysine would cause the helix to tilt away from the positively charged Arg 438 and His 435 due to the electrostatic repulsion. The mutation also facilitates a possible interaction between Lys 463 and Thr 437 through hydrogen bonds. All of this would contribute to the decreased flexibility of the N terminal loop, but have no or little impact on the overall fold. This was verified in trypsin digestion assays (Supplementary Figure S4) where wild-type STAS was digested faster than STAS A463K and the degraded band in A463K could be detected by anti-His antibody. However, since the N-terminal region of the STAS domain is likely to contact the TM domain of the SLC26 transporter, the stabilizing effect of A463K is probably an artificial one and may not represent the corresponding disease-causing mutation in vivo.
Both Thr 469 (Ser 549 in rat prestin, Arg 554 in human SLC26A3; Figure 1 ) and Asp 470 (Asp 550 in prestin and Cys 565 in human SLC26A4; Figure 1 ) are distributed on the surface of STAS α1 and are exposed to the aqueous environment ( Figure 1B) . The secondary structures and melting temperatures of T469Q and D470Y showed mild changes ( Figure 4 and Supplementary  Table S1 ), but D470Y showed a drastic red-shift of wavelength combined with a decreased intrinsic fluorescence intensity compared with T469Q ( Figure 5 ). This could be explained by the different effects on the size and charge of the residues that the two mutations bring, as threonine to glutamine is a relatively minor change compared with an aspartic acid to tyrosine mutation. However in the human SLC26A3 protein, Arg 554 is a strong positively charged residue and mutation to glutamine could strongly affect protein folding.
Mutation of Asp 470 to tyrosine would eliminate the negative charge of aspartic acid and increase the volume of the original residue. A change from aspartic acid to tyrosine also decreases the solubility of the wild-type protein, perhaps due to replacement of a charged residue with a hydrophobic residue. D470Y may also contribute to the oligomerization of the protein by promoting surface-surface hydrophobic interactions. This can be seen from the gel-filtration profile in which D470Y has a larger degree of oligomerization compared with T469Q. Therefore, in human SLC26A4, we suspect that mutation of cysteine into tyrosine may also lead to the oligomerization of the natural proteins through non-native surface hydrophobic interactions (π-π interactions). Furthermore, a charge-charge interaction was observed between Asp 470 and Arg 474 with a distance of 2.9 Å (1 Å = 0.1 nm) (Supplementary Figure S7C) Figure S8B ). As shown in the fluorescence emission assay, K484N has a significant red-shift compared with wild-type and most of other mutants. The strong bond between Lys 484 and Asp 486 in DauA seems have evolved into hydrogen bonds between aspartic acid and threonine/serine (Figure 1 , arrow '6') in rat prestin (equalivalent to human SLC26A5) and human SLC26A3. As previously indicated, molecular dynamics showed that linker regions between α1 and α2 in human pendrin tend to be more flexible than in rat or bacteria [66] , therefore the unfolding effect of the equivalent mutants between α1 and α2 in human may not be as dramatic as in bacteria and needs further investigation.
Leu 506 (Tyr 667 in rat prestin, Phe 683 in human SLC26A4; Figure 1 and Supplementary Figure S1B ) is located at the end of the α2 and probably interacts with Leu 512 (valine in rat and human) through hydrophobic interactions (Supplementary Figure S8C) . By mutating leucine into serine, the hydrophobic region may be compromised since serine is hydrophilic and tends to face the aqueous environment. The mutations may also contribute to the increased interaction between Ser 506 and Arg 536 through hydrogen bonds (Supplementary Figure S8C) . All of these changes would enable the protein to become less compact. Mutation of the corresponding aromatic residues in human SLC26A4 may have similar effect in eliminating the hydrophobic interactions between Tyr 667 and Val 674 (rat prestin) (Supplementary Figure S8C) .
Mutations in α4
Asn 542 , Arg 544 , Ala 545 and Ala 546 are all distributed on the last α-helix (α4) of the STAS domain (Supplementary Figure S9) is the most conserved residue in both DauA and human homologues, and it is constantly buried in the hydrophobic core region. Finally, alanine is a strong α-helix former and mutation to valine (DauA A546V and SLC26A2 A715V), a strong β-strand former, would be expected to destabilize the α4 helix.
The corresponding residues of Asn 542 and Arg 544 in human SLC26A4 are Thr 721 and His 723 respectively (Figure 1 ). These surface residues are exposed to the aqueous solvent environment. Mutations at these two sites (N542M and R544A) to hydrophobic residues would decrease the solubility of the protein and increase the protein's propensity to oligomerize and aggregate through surface hydrophobic interactions. A decreased expression and solubility of these mutants can be seen in the expression and purification assays probably due to formation of insoluble inclusion bodies.
Overall, we conclude that most of these disease-causing mutants changed the natural folding of wild-type protein and decreased the stability of STAS domain resulting in selfassociation and aggregation in most cases. The present study may provide important information of the STAS working mechanism in regulating SLC26 transporter function. In particular, our studies indicate that, although the mutations caused protein misfolding, it is important to examine the mutations on a case-by-case basis as they vary in the effects on the protein. We are now examining the effect of these STAS mutations on the cell-surface expression of the intact human SLC26 proteins in transfected HEK-293 cells. We hypothesize that the misfolding of the STAS domain will lead to aggregation and retention of the proteins in the endoplasmic reticulum by the quality control system of the cell.
AUTHOR CONTRIBUTION
All experiments were carried out by Xiaoyun Bai, who wrote the manuscript and prepared the figures. Reinhart Reithmeier and Trevor Moraes developed and supervised the research project, and edited the manuscript before submission.
ACKNOWLEDGMENTS
We thank Jing Li for providing the DauA cDNA. Fan Xia and Chloe Rapp are thanked for project discussion. Charles Calmettes, Christine Lai, Andrew Judd, Yogesh Hooda and Anastassia Pogoutse are thanked for help in protein purification and trypsin digestion assay. Nardin Nano, Elisa Leung, Sam and Kaiyu Liu in Dr Walid Houry's laboratory are thanked for technical support in CD and urea denaturation assays. Anti-LepB was received as a gift from Dr Jan-Willem de Gier. 
